myricanol has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, K; Chen, X; Dai, G; Ren, Z; Tong, Y; Yang, F; Ying, X | 1 |
1 other study(ies) available for myricanol and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Myricanol induces apoptotic cell death and anti-tumor activity in non-small cell lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diarylheptanoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Mice; Mice, Nude; Polyethylene Glycols; Survivin; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |